CDER New August 26, 2016

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

 

August 25, 2016


New and Generic Drug Approvals

August 24, 2016

Drug Name Active Ingredient Dosage Form/Route Sponsor Submission Type
Amoxicillin and Clavulanate Potassium amoxicillin; clavulanate potassium Tablet;Oral Hikma Pharms Approval
Calan verapamil hydrochloride Tablet;Oral Gd Searle Llc Labeling Revision
Calan verapamil hydrochloride Injectable;Injection Gd Searle Llc Labeling Revision
Calan Sr verapamil hydrochloride Tablet, Extended Release;Oral Pfizer Labeling Revision
Codeine Sulfate codeine sulfate Solution;Oral Roxane Manufacturing Change or Addition
Covera-Hs verapamil hydrochloride Tablet, Extended Release;Oral Gd Searle Llc Labeling Revision
Ethacrynate Sodium ethacrynate sodium Injectable;Injection Mylan Institutional Approval
Fortamet metformin hydrochloride Tablet, Extended Release;Oral Andrx Labs Llc Manufacturing Change or Addition
Pacitaxel paclitaxel Injectable;Injection Gland Pharma Ltd Approval
Paroxetine paroxetine Tablet, Extended Release;Oral Lupin Ltd Tentative Approval
Rhinocort budesonide Spray, Metered;Nasal Astrazeneca Pharms Labeling Revision
Rhinocort Allergy budesonide Spray, Metered;Nasal Astrazeneca Pharms Labeling Revision
Trospium Chloride trospium chloride Tablet;Oral Invagen Pharms Approval
Xarelto rivaroxaban Tablet; Oral Janssen Pharms Manufacturing Change or Addition

 

 

Searching the Orange Book is now faster and easier with our new mobile app!

Download Orange Book Express

 Download iOS App Download Android App Black


This email was sent to rssproject471@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332) Powered by GovDelivery

Postingan terkait:

Belum ada tanggapan untuk "CDER New August 26, 2016"

Post a Comment